Insilico Medicine raises USD 255 Million for AI drug discoveryInsilico Medicine, a Hong Kong-based global leader in end-to-end artificial intelligence for target discovery, small molecule chem...
Horizon Dishes Out Million Dollars to get Arrowhead's RNAi DrugArrowhead Pharmaceuticals and Horizon Therapeutics have announced a research and development collaboration to advance the treatme...
Mallinckrodt earns FDA nod for regenerative skin therapy for burnsMallinckrodt plc’s Stratagraft gained FDA approval for use in deep partial-thickness thermal burns. The company said regenerat...
Aelis Farma pockets USD 30 Million upfront in cannabis use disorder deal with IndiviorIndivior speculates that Aelis Farma has what it takes to bring cannabis use disorder therapy into the cli...
Verdict for Biogen’s Long-Awaited Alzheimer’s Drug Is Finally Here The USFDA finally gave approval to eagerly-anticipated Biogen’s Drug Aducanumab for the treatment of Alzheimer’s d...
Pieris Pharmaceuticals declares Respiratory and Ophthalmology deal with GenentechPieris, a clinical-stage biotechnology company, declared that it has entered into a multi-program research coll...
According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....
Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a de.....
Prostate Cancer is the second most common malignancy in men worldwide, after lung cancer. Most Prost.....
Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...
Data and analytics today are playing a major role in the organization’s growth. Stakeho...
Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal i...
The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...
Neurological disorders are one of the major causes of death and disability across the g...
